RxDoctor Payments Data

Nonna Livits, MD

Family Medicine · Canton, GANPI 1457747313

Payments from drug & device makers

$1,387in general payments, 2019–2025

Across 75 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$230
  • Amgen$216
  • Novartis$166
  • AstraZeneca$164
  • GSK$128
  • Nevro Corp.$101
  • plus $381 from 12 others

What the payments were for

  • Food & beverage$1,387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,387 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$216,500
Medicare patients
397
Services billed
5,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide144$162,935
JanuviaSitagliptin Phosphate44$39,457
FarxigaDapagliflozin Propanediol34$37,592
MounjaroTirzepatide29$32,691
TrulicityDulaglutide15$31,242
JardianceEmpagliflozin25$25,795
EliquisApixaban18$19,423
Tresiba Flextouch U-100Insulin Degludec16$13,319
Tresiba Flextouch U-200Insulin Degludec17$11,703
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$11,306
InvokanaCanagliflozin13$7,128
SynthroidLevothyroxine Sodium114$6,998
Levothyroxine Sodium595$5,877
Spiriva HandihalerTiotropium Bromide11$5,669
SymbicortBudesonide/Formoterol Fumarate22$5,275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$230$162,935144 claims
AstraZenecaFarxiga, Symbicort$164$42,86756 claims
Boehringer IngelheimJardiance$19$25,79525 claims
PfizerEliquis$12$19,42318 claims
GSKTrelegy Ellipta$128$11,30611 claims
AbbVieSynthroid$89$6,998114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →